114 related articles for article (PubMed ID: 38524880)
1. A Novel DNA Aptamer Probe Recognizing Castration Resistant Prostate Cancer in vitro and in vivo Based on Cell-SELEX.
Zhong J; Liu D; Yang Q; Ding J; Chen X
Drug Des Devel Ther; 2024; 18():859-870. PubMed ID: 38524880
[TBL] [Abstract][Full Text] [Related]
2. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
3. DNA aptamer evolved by cell-SELEX for recognition of prostate cancer.
Wang Y; Luo Y; Bing T; Chen Z; Lu M; Zhang N; Shangguan D; Gao X
PLoS One; 2014; 9(6):e100243. PubMed ID: 24956390
[TBL] [Abstract][Full Text] [Related]
4. Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA
Tai Z; Ma J; Ding J; Pan H; Chai R; Zhu C; Cui Z; Chen Z; Zhu Q
Int J Nanomedicine; 2020; 15():10305-10320. PubMed ID: 33376323
[TBL] [Abstract][Full Text] [Related]
5. Aptamer-Conjugated Multifunctional Polymeric Nanoparticles as Cancer-Targeted, MRI-Ultrasensitive Drug Delivery Systems for Treatment of Castration-Resistant Prostate Cancer.
Fang Y; Lin S; Yang F; Situ J; Lin S; Luo Y
Biomed Res Int; 2020; 2020():9186583. PubMed ID: 32420382
[TBL] [Abstract][Full Text] [Related]
6. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
Liu M; Wang Z; Tan T; Chen Z; Mou X; Yu X; Deng Y; Lu G; He N
Theranostics; 2018; 8(20):5772-5783. PubMed ID: 30555580
[TBL] [Abstract][Full Text] [Related]
7. Selection and characterization of DNA aptamer for metastatic prostate cancer recognition and tissue imaging.
Duan M; Long Y; Yang C; Wu X; Sun Y; Li J; Hu X; Lin W; Han D; Zhao Y; Liu J; Ye M; Tan W
Oncotarget; 2016 Jun; 7(24):36436-36446. PubMed ID: 27183906
[TBL] [Abstract][Full Text] [Related]
8. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer.
Zhang X; He Z; Xiang L; Li L; Zhang H; Lin F; Cao H
Drug Des Devel Ther; 2019; 13():1357-1372. PubMed ID: 31118572
[No Abstract] [Full Text] [Related]
9. Cancer cell targeting using multiple aptamers conjugated on nanorods.
Huang YF; Chang HT; Tan W
Anal Chem; 2008 Feb; 80(3):567-72. PubMed ID: 18166023
[TBL] [Abstract][Full Text] [Related]
10. Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer.
Welti J; Rodrigues DN; Sharp A; Sun S; Lorente D; Riisnaes R; Figueiredo I; Zafeiriou Z; Rescigno P; de Bono JS; Plymate SR
Eur Urol; 2016 Oct; 70(4):599-608. PubMed ID: 27117751
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic applications of gastric carcinoma cell aptamers in vitro and in vivo.
Ding F; Guo S; Xie M; Luo W; Yuan C; Huang W; Zhou Y; Zhang XL; Zhou X
Talanta; 2015 Mar; 134():30-36. PubMed ID: 25618637
[TBL] [Abstract][Full Text] [Related]
12. Rooibos suppresses proliferation of castration-resistant prostate cancer cells via inhibition of Akt signaling.
Huang SH; Tseng JC; Lin CY; Kuo YY; Wang BJ; Kao YH; Muller CJF; Joubert E; Chuu CP
Phytomedicine; 2019 Nov; 64():153068. PubMed ID: 31419729
[TBL] [Abstract][Full Text] [Related]
13. Expression of MUS81 Mediates the Sensitivity of Castration-Resistant Prostate Cancer to Olaparib.
Gong L; Tang Y; Jiang L; Tang W; Luo S
J Immunol Res; 2022; 2022():4065580. PubMed ID: 35910852
[TBL] [Abstract][Full Text] [Related]
14. Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage.
Zhang DF; Yang ZC; Chen JQ; Jin XX; Qiu YD; Chen XJ; Shi HY; Liu ZG; Wang MS; Liang G; Zheng XH
BMC Complement Med Ther; 2021 Jul; 21(1):195. PubMed ID: 34229670
[TBL] [Abstract][Full Text] [Related]
15. RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.
Linder A; Larsson K; Welén K; Damber JE
Prostate; 2020 Aug; 80(11):799-810. PubMed ID: 32449815
[TBL] [Abstract][Full Text] [Related]
16. Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy.
Cheng Q; Butler W; Zhou Y; Zhang H; Tang L; Perkinson K; Chen X; Jiang XS; McCall SJ; Inman BA; Huang J
Eur Urol; 2022 May; 81(5):446-455. PubMed ID: 35058087
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer.
Shi SJ; Wang LJ; Han DH; Wu JH; Jiao D; Zhang KL; Chen JW; Li Y; Yang F; Zhang JL; Zheng GX; Yang AG; Zhao AZ; Qin WJ; Wen WH
Theranostics; 2019; 9(5):1247-1263. PubMed ID: 30867828
[No Abstract] [Full Text] [Related]
18. Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.
Moll JM; Hofland J; Teubel WJ; de Ridder CMA; Taylor AE; Graeser R; Arlt W; Jenster GW; van Weerden WM
Prostate; 2022 Apr; 82(5):505-516. PubMed ID: 35037287
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
[TBL] [Abstract][Full Text] [Related]
20. In vitro selection of DNA aptamers recognizing drug-resistant ovarian cancer by cell-SELEX.
He J; Wang J; Zhang N; Shen L; Wang L; Xiao X; Wang Y; Bing T; Liu X; Li S; Shangguan D
Talanta; 2019 Mar; 194():437-445. PubMed ID: 30609555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
